Solid Biosciences (SLDB) Assets Average (2018 - 2024)
Historic Assets Average for Solid Biosciences (SLDB) over the last 7 years, with Q3 2024 value amounting to $221.4 million.
- Solid Biosciences' Assets Average rose 1370.09% to $221.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $221.4 million, marking a year-over-year increase of 1370.09%. This contributed to the annual value of $212.6 million for FY2023, which is 1368.99% down from last year.
- According to the latest figures from Q3 2024, Solid Biosciences' Assets Average is $221.4 million, which was up 1370.09% from $239.8 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Assets Average registered a high of $275.6 million during Q2 2021, and its lowest value of $49.2 million during Q3 2020.
- Its 5-year average for Assets Average is $192.5 million, with a median of $217.2 million in 2023.
- Per our database at Business Quant, Solid Biosciences' Assets Average crashed by 5666.02% in 2020 and then soared by 42278.41% in 2021.
- Over the past 5 years, Solid Biosciences' Assets Average (Quarter) stood at $105.8 million in 2020, then soared by 127.4% to $240.7 million in 2021, then fell by 7.61% to $222.4 million in 2022, then fell by 21.37% to $174.8 million in 2023, then grew by 26.64% to $221.4 million in 2024.
- Its Assets Average stands at $221.4 million for Q3 2024, versus $239.8 million for Q2 2024 and $206.8 million for Q1 2024.